HALO logo
halo search icon
Immuron Limited Sponsored ADR
Immuron Limited Sponsored ADR
IMRN · NAS

Immuron Limited Sponsored ADR

US$0.98

Price Arrow-0.01 (-1.01%)
21/05/2026 04:00:01 PM
All-ConsensusEngulfing Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Immuron Limited Sponsored ADR Overview

IMRN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About IMRN

icon

Website

Immuron Limited Sponsored ADR

icon

Telephone

61.3.8892.4802

icon

Address

Unit 10, 25-37 Chapman Street, Blackburn, Victoria (VIC) 3131

Description

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.

IMRN Price Chart

Key Stats

Market Cap

US$7.48M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.68 - 2.39

Trade Value (12mth)

US$90,179.00

1 week

-1.49%

1 month

12.78%

YTD

24.53%

1 year

-45.9%

All time high

28.99

Key Fundamentals

EPS 3 yr Growth

60.90%

EBITDA Margin

-92.20%

Operating Cashflow

-$4m

Free Cash Flow Return

-56.10%

ROIC

-48.70%

Interest Coverage

-919.70

Quick Ratio

4.20

Other Data

Shares Outstanding (Fully Diluted)

7m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

IMRN Announcements

Latest Announcements

DateAnnouncements
08 May 26
30 April 26
17 April 26
13 April 26
06 March 26

IMRN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.45-0.8-0.59locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.45-0.8-0.59locklocklock
Growth
%locklocklocklock-22.9-78.426.7locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Immuron Limited Sponsored ADR (IMRN:NAS)?
Halo FAQ
The current share price of Immuron Limited Sponsored ADR (IMRN:NAS) is USD$0.98.
What is the 52-week high share price for Immuron Limited Sponsored ADR (IMRN:NAS)?
Halo FAQ
The 52-week high share price for Immuron Limited Sponsored ADR (IMRN:NAS) is USD$2.39.
What is the 52-week low share price for Immuron Limited Sponsored ADR (IMRN:NAS)?
Halo FAQ
The 52-week low share price for Immuron Limited Sponsored ADR (IMRN:NAS) is USD$0.68.
What is the dividend yield for Immuron Limited Sponsored ADR (IMRN:NAS)?
Halo FAQ
Immuron Limited Sponsored ADR (IMRN:NAS) does not pay a dividend.
What was Immuron Limited Sponsored ADR (IMRN:NAS) last dividend payment?
Halo FAQ
Immuron Limited Sponsored ADR (IMRN:NAS) does not pay a dividend.
What is the franking level for Immuron Limited Sponsored ADR (IMRN:NAS)?
Halo FAQ
Immuron Limited Sponsored ADR (IMRN:NAS) has a franking level of 0.00%.
In which sector is Immuron Limited Sponsored ADR (IMRN:NAS) classified?
Halo FAQ
Immuron Limited Sponsored ADR (IMRN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.